Are you worried about being able to pay your monthly bills?As US household debt continues to rise, Bloomberg reporters want to hear how you are managing living expenses: https://t.co/f96AIdwo2z https://t.co/L2J1mGCq6V ...

Are you worried about being able to pay your monthly bills?As US household debt continues to rise, Bloomberg reporters want to hear how you are managing living expenses: https://t.co/f96AIdwo2z https://t.co/aO9VFLHqkW ...

Katie Gatti Tassin couldn’t understand why her savings were so meager. Then she tallied her beauty expenses: “I thought my calculator had added an extra zero.”She decided it was time to hop off what I call the “Hot Girl Hamster Wheel.”🔗 Read more: https://t.co/yxDqkYsrR2 https://t.co/ikMmhFYLr9 ...

Are you worried about being able to pay your monthly bills?As US household debt continues to rise, Bloomberg reporters want to hear how you are managing living expenses: https://t.co/f96AIdwo2z https://t.co/wVhdpgFEwl ...

Are you worried about being able to pay your monthly bills?As US household debt continues to rise, Bloomberg reporters want to hear how you are managing living expenses: https://t.co/f96AIdwo2z https://t.co/DeFh0RkhuH ...

Learn about the best tools and simple steps to cut unnecessary expenses and keep more money in your pocket. https://t.co/A3bvhlFgiC ...

A 529 plan is a tax-advantaged account that can be used to pay for qualified education expenses, including college, K–12, and apprenticeship programs. https://t.co/h96g1HkdGK ...

Core Insights - Medtronic plc is expanding its global presence in the Cardiovascular business, which is expected to support growth in upcoming quarters [1] - The company is gaining market share in Neuroscience, particularly in Cranial and Spinal technologies, aided by strong growth and competitor exits [1] - International expansion remains robust, contributing significantly to revenue growth [1] Cardiovascular Business - Medtronic's cardiac rhythm management segment continues to lead the market, driven by strong performance in Defibrillation Solutions and cardiac pacing therapies [3] - The fiscal third quarter of 2025 saw the cardiovascular portfolio grow in the mid-single digits, with the Cardiac Ablation Solutions business achieving 22% growth [4] - The next-generation Micra AV2 and VR2 leadless pacemakers are key drivers of growth as they penetrate new and existing markets [3] Neuroscience Portfolio - The Neuroscience portfolio, particularly Cranial and Spinal technologies, is experiencing strong growth, with Medtronic gaining market share as competitors exit the market [5] - In Neuromodulation, the Inceptiv spinal cord stimulator drove 12% growth in the fiscal third quarter, while brain modulation saw 15% global growth and 26% growth in the U.S. [6] International Expansion - Nearly 49% of Medtronic's revenues were generated internationally in the third quarter of fiscal 2025, with emerging markets growing in high-single digits [7] - Significant growth was noted in India (high-teens), Eastern Europe (mid-teens), and low-double-digit growth in Southeast Asia, the Middle East, and Africa [9] Financial Performance - Medtronic has a market capitalization of $108.05 billion and an earnings yield of 6.92%, significantly higher than the industry's yield of 0.05% [2] - The Zacks Consensus Estimate for fiscal 2025 earnings per share (EPS) is $5.46, with revenues estimated at $33.48 billion, reflecting a 3.4% increase from the previous year [12]

Core Viewpoint - Deere & Company is expected to report second-quarter fiscal 2025 results on May 15, with strong demand from product launches but challenges from elevated production expenses and low commodity prices impacting performance [1]. Group 1: Factors Influencing Q2 Performance - Low commodity prices and weak farmer spending have led to lower shipment volumes, negatively affecting the company's fiscal second-quarter performance [2]. - High production expenses, along with increased selling, administrative, and research and development costs, are anticipated to impact the company's margins [3]. - The company is reviewing its cost structure to improve margins, with favorable price realization expected to offset some of the higher material and freight costs [4]. Group 2: Segment Projections for Q2 - The Production & Precision Agriculture segment is projected to generate revenues of $4.61 billion, a year-over-year decrease of 23.9%, with operating profit expected to fall 62.5% to $619 million [5]. - The Small Agriculture & Turf segment's revenues are estimated at $2.78 billion, indicating a 12.6% decline, with operating profit expected to decrease by 15.1% to $485 million [6]. - The Construction & Forestry segment's sales are estimated at $3.29 billion, a 14.4% dip, with operating profit predicted to drop 12% to $588 million [7]. - The Financial Services segment is projected to have revenues of $1.48 billion, a 6.7% increase, with operating profit estimated at $232 million [8]. Group 3: Overall Q2 Expectations - The Zacks Consensus Estimate for Deere's earnings has decreased by 1.1% to $5.68 per share, implying a 33.4% decline from the previous year, with revenue expectations at $10.6 billion, a 21.7% year-over-year decline [9]. - The earnings surprise history shows that Deere has beaten the Zacks Consensus Estimates in the past four quarters, with an average surprise of 8.9% [10]. Group 4: Earnings Prediction Model - The current Earnings ESP for Deere is -0.03%, indicating that the model does not predict an earnings beat this time [11]. - Deere holds a Zacks Rank of 3, suggesting a hold position [12]. Group 5: Share Price Performance - Deere's shares have increased by 22.6% over the past year, outperforming the industry's growth of 18.5% [13].

Main Street Capital Corporation’s (MAIN) first-quarter 2025 adjusted net investment income of $1.01 per share surpassed the Zacks Consensus Estimate of $1 per share. However, the reported figure compares unfavorably with $1.05 per share in the year-ago quarter.The results benefited from an improvement in the total investment income. However, an increase in expenses acted as a spoilsport. Distributable net investment income (GAAP basis) was $94.8 million, marginally up from the prior-year quarter.MAIN’s Tota ...